- Alkermes EVP R&D, Chief Medical Officer Craig C. Hopkinson sold 9,000 ordinary shares on April 1, 2026 at a weighted average price of USD 35.51.
- Hopkinson exercised employee stock options for 5,000 ordinary shares on April 1, 2026 at an exercise price of USD 19.34.
- Directly held ordinary shares totaled 85,389 following transactions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alkermes plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001520262-26-000065), on April 01, 2026, and is solely responsible for the information contained therein.
Comments